Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

Vincent F Simmon

首页> 外文期刊>Trials >Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

【24h】

Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

机译：回应：脑试验：缓激肽B2受体拮抗剂（Anatibant）在脑外伤患者中进行的随机安慰剂对照试验

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

A response to and comment on The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury , by Haleema Shakur, Ian Roberts, et al.

机译：对脑部试验的回应和评论：Haleema Shakur，Ian Roberts等在脑外伤患者中进行缓激肽B2受体拮抗剂（Anatibant）的随机安慰剂对照试验。

著录项

来源
《Trials》 |2009年第1期|共页
作者
Vincent F Simmon;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类自然科学研究方法;
关键词

相似文献

外文文献
中文文献
专利

1. The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury [J] . Haleema Shakur, Peter Andrews, Toomas Asser, Trials . 2009,第1期

机译：脑试验：缓激肽B2受体拮抗剂（Anatibant）在颅脑外伤患者中的一项随机安慰剂对照试验
2. Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply [J] . Ian Roberts, Haleema Shakur Trials . 2009,第1期

机译：回应：脑试验：缓激肽B2受体拮抗剂（Anatibant）在颅脑外伤患者中的一项随机安慰剂对照试验-作者的回复
3. A Single Dose, Three-Arm, Placebo-Controlled, Phase I Study of the Bradykinin B2 Receptor Antagonist Anatibant (LF16-0687Ms) in Patients with Severe Traumatic Brain Injury. [J] . Marmarou A, Guy M, Murphey L, Journal of neurotrauma . 2005,第12期

机译：单剂量，三臂，安慰剂对照的严重创伤性脑损伤患者缓激肽B2受体拮抗剂激动剂（LF16-0687Ms）的I期研究。
4. Is voluntary postural control training the trigger factor for brain integration in traumatic brain injury patients? [C] . Zhavoronkova L., Zharikova A., Maksakova O., World Congress of Neurorehabilitation . 2010

机译：自愿姿势控制训练脑均衡患者脑整合的触发因子吗？
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Response to: The BRAIN TRIAL: a randomised placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury [O] . Vincent F Simmon 2009

机译：回应：脑试验：缓激肽B2受体拮抗剂（Anatibant）在颅脑外伤患者中的一项随机安慰剂对照试验
7. Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury [O] . Simmon Vincent F 2009

机译：回应：脑试验：缓激肽B2受体拮抗剂（Anatibant）在颅脑外伤患者中的一项随机安慰剂对照试验
8. Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury [R] . Jaffee, M. S. 2009

机译：西酞普兰治疗创伤性脑损伤后焦虑障碍的随机安慰剂对照试验

Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

摘要

著录项

相似文献

相关主题

期刊订阅